Undersøgelserne omfattede over 500 voksne og børn, der blev behandlet i forskellige tidsrum med mitotan, anvendt enten alene eller i kombination med andre kræftmidler.
The studies included over 500 adults and children, who were treated for various lengths of time with mitotane, either alone or in combination with other anticancer medicines.